Clinical trial • Phase III • Other
Clinical trial
Phase III trial. None/Not specified-controlled. 18 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 08-01-2025
- First CTIS Authorization Date
- 22-01-2025
Trial design
None/Not specified-controlled Phase III trial across 1 site in Denmark.
- Comparator
- None/Not specified
- Target Sample Size
- 18
Eligibility
Recruits 18 No vulnerable populations selected..
- Vulnerable Population
- No vulnerable populations selected.
Recruitment
- Planned Sample Size
- 18
- Recruitment Window Months
- 41
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 18
Denmark
- Earliest CTIS Part Ii Submission Date
- 17-01-2025
- Latest Decision Or Authorization Date
- 22-01-2025
- Processing Time Days
- 5
- Number Of Sites
- 1
- Number Of Participants
- 18
Sites
- Site Name
- Rigshospitalet
- Department Name
- Neurobiology Research Unit
- Contact Person Name
- Gitte Moos Knudsen
- Contact Person Email
- gmk@nru.dk
- Number Of Participants
- 18
Sponsor
Primary sponsor
- Full Name
- Rigshospitalet
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- Denmark
Related trials
Other published trials that may interest you.